RESUMO
Hepato-cellular carcinoma [HCC] is the fourth most common malignant tumor in the world and is responsible for an estimated one million deaths annually. This study was carried out on 35 patients with hepatic tumors. The aim was to study the impact of the underlying liver disease, tumor pathology, and extent of resection on the outcome of hepatic resection for liver tumors. All patients were subjected to complete history taking, thorough clinical examination, laboratory and imaging studies followed by hepatic resection based on the preoperative data. Follow up of patients was done to determine the perioperative complications, disease-free period, overall survival, tumor recurrence and tumor-related deaths in cases of malignant liver tumors. The indications for hepatic resection were haemangioma [in 2 patients], HCC [in 27 patients] and secondary malignancy [in 6 patients]. Hepatic resections were hemi-hepatectomy in 16, extended hepatectomy in 4 and left lateral lobectomy in 7. The remaining 8 cases included resections of one to three segments or consisted of non-anatomical wedge resections. 23 patients had no perioperative complications. Minor morbidity occurred in 8 patients and major morbidity in 4 patients. There were 2 perioperative deaths. The median survival in patients who underwent hepatic resection for HCC was 30.6 months [15.07-46.17] and the survival rates at 1, 3 and 5 years were 83.3, 63.6 and 34.1% respectively. There is now ample evidence that surgical resection, if possible, remains the best option for treating malignant liver tumors as it offers the best hope of cure in such patients